Dong Jing, Gao Lingqi, Lu Wenqing, Xu Zifeng, Zheng Jijian
Department of Anesthesiology, Shanghai First People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Department of Anesthesiology, International Peace Maternal and Child Health Hospital, Shanghai, China.
PLoS One. 2014 Dec 2;9(12):e114231. doi: 10.1371/journal.pone.0114231. eCollection 2014.
Rocuronium is an acceptable alternative when succinylcholine is contraindicated for facilitating the endotracheal intubation. However, the onset time of rocuronium for good intubation condition is still slower than that condition of succinylcholine. This study systematically investigated the most efficacious pharmacological interventions for accelerating the onset time of rocuronium.
Medline, Embase, Cochrane Library databases, www.clinicaltrials.gov, and hand searching from the reference lists of identified papers were searched for randomized controlled trials comparing drug interventions with placebo or another drug to shorten the onset time of rocuronium. Statistical analyses were performed using RevMan5.2 and ADDIS 1.16.5 softwares. Mean differences (MDs) with their 95% confidence intervals (95% CIs) were used to analyze the effects of drug interventions on the onset time of rocuronium.
43 randomized controlled trials with 2,465 patients were analyzed. The average onset time of rocuronium was 102.4±24.9 s. Priming with rocuronium [Mean difference (MD) -21.0 s, 95% confidence interval (95% CI) (-27.6 to -14.3 s)], pretreatment with ephedrine [-22.3 s (-29.1 to -15.5 s)], pretreatment with magnesium sulphate [-28.2 s (-50.9 to -5.6 s)] were all effective in reducing the onset time of rocuronium. Statistical testing of indirect comparisons showed that rocuronium priming, pretreatment with ephedrine, and pretreatment with magnesium sulphate had the similar efficacy.
Rocuronium priming, pretreatment with ephedrine, and pretreatment with magnesium sulphate were all effective in accelerating the onset time of rocuronium, and furthermore their efficacies were similar. Considering the convenience and efficacy, priming with rocuronium is recommended for accelerating the onset time of rocuronium. However, more strict clinical trials are still needed to reach a more solid conclusion due to the large heterogeneities exist among different studies.
当琥珀酰胆碱因禁忌而不能用于辅助气管插管时,罗库溴铵是一种可接受的替代药物。然而,罗库溴铵达到良好插管条件的起效时间仍比琥珀酰胆碱慢。本研究系统地调查了加速罗库溴铵起效时间的最有效药物干预措施。
检索Medline、Embase、Cochrane图书馆数据库、www.clinicaltrials.gov,并通过手工检索已识别论文的参考文献列表,以查找比较药物干预与安慰剂或另一种药物以缩短罗库溴铵起效时间的随机对照试验。使用RevMan5.2和ADDIS 1.16.5软件进行统计分析。采用平均差值(MD)及其95%置信区间(95%CI)分析药物干预对罗库溴铵起效时间的影响。
分析了43项随机对照试验,共2465例患者。罗库溴铵的平均起效时间为102.4±24.9秒。罗库溴铵预注[平均差值(MD)-21.0秒,95%置信区间(95%CI)(-27.6至-14.3秒)]、麻黄碱预处理[-22.3秒(-29.1至-15.5秒)]、硫酸镁预处理[-28.2秒(-50.9至-5.6秒)]均能有效缩短罗库溴铵的起效时间。间接比较的统计检验表明,罗库溴铵预注、麻黄碱预处理和硫酸镁预处理具有相似的疗效。
罗库溴铵预注、麻黄碱预处理和硫酸镁预处理均能有效加速罗库溴铵的起效时间,且疗效相似。考虑到便利性和有效性,推荐罗库溴铵预注以加速罗库溴铵的起效时间。然而,由于不同研究之间存在较大异质性,仍需要更严格的临床试验才能得出更可靠的结论。